Tretten
Drug
Novo Nordisk AS
Total Payments
$293,241
Transactions
140
Doctors
42
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $49.80 | 2 | 2 |
| 2022 | $96.60 | 7 | 7 |
| 2021 | $10,075 | 11 | 5 |
| 2020 | $4,083 | 9 | 5 |
| 2019 | $98,208 | 39 | 6 |
| 2018 | $84,258 | 36 | 15 |
| 2017 | $96,471 | 36 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $282,936 | 77 | 96.5% |
| Travel and Lodging | $8,674 | 3 | 3.0% |
| Food and Beverage | $985.36 | 40 | 0.3% |
| Education | $645.40 | 20 | 0.2% |
Payments by Type
Research
$282,936
77 transactions
General
$10,305
63 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NN1841-3868 | Novo Nordisk AS | $146,993 | 0 |
| Development of an enhanced fXIII activity assay by hybrid enzyme capture/ELISA | Novo Nordisk Inc | $98,132 | 0 |
| Factor XIII as a hemostatic agent in hemophilia | Novo Nordisk Inc | $23,471 | 0 |
| NN1841-3720 | Novo Nordisk AS | $14,341 | 0 |
Top Doctors Receiving Payments for Tretten — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Trumann, AR | $16.84 | 1 |
| , M.D | Hospitalist | Trumann, AR | $16.84 | 1 |
| , MD | Pediatric Hematology-Oncology | West Palm Beach, FL | $16.83 | 1 |
| , M.D | Internal Medicine | Warner Robins, GA | $16.41 | 1 |
| , MD | Internal Medicine | Jacksonville, FL | $15.46 | 1 |
| , M.D | Internal Medicine | Royal Oak, MI | $14.54 | 1 |
| , MD | Hematology & Oncology | Royal Oak, MI | $14.54 | 1 |
| , MD | Family Medicine | Lake City, FL | $14.32 | 1 |
| , MD | Family Medicine | Lake City, FL | $14.32 | 1 |
| , M.D | Emergency Medicine | London, KY | $11.45 | 1 |
| , MD | Internal Medicine | North Charleston, SC | $10.59 | 1 |
| , D.O | Family Medicine | Farmington, MO | $10.20 | 1 |
| , M.D | Internal Medicine | Melrose Park, IL | $7.08 | 1 |
| Kristine Taylor | Nurse Practitioner | Fort Wayne, IN | $5.62 | 1 |
| , MD | Legal Medicine | Summit, IL | $5.29 | 1 |
| , MD | Family Medicine | El Paso, TX | $4.83 | 1 |
| , MD | Internal Medicine | Three Rivers, MI | $3.89 | 1 |
| , M.D | Internal Medicine | El Paso, TX | $3.37 | 1 |
Ad
Manufacturing Companies
- Novo Nordisk AS $170,394
- Novo Nordisk Inc $122,848
Product Information
- Type Drug
- Total Payments $293,241
- Total Doctors 42
- Transactions 140
About Tretten
Tretten is a drug associated with $293,241 in payments to 42 healthcare providers, recorded across 140 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk AS.
Payment data is available from 2017 to 2023. In 2023, $49.80 was paid across 2 transactions to 2 doctors.
The most common payment nature for Tretten is "Unspecified" ($282,936, 96.5% of total).
Tretten is associated with 4 research studies, including "NN1841-3868" ($146,993).